Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Vivus
shares jump on results from obesity drug 6:45 AM 9/9/2009
MarketWatch
Vivus Inc announced positive results from two Phase 3 studies of its
investigational obesity treatment Qnexa.
...
Botox
May Get $1 Billion Face Lift as Allergan Migraine
Drug 5:14 AM 9/9/2009
Bloomberg
Allergan
Inc’s Botox could be worth $1 billion in added sales yearly as a drug that prevents migraine headaches.
...
FDA
approves Ista's itchy eye treatment Bepreve 2:12 AM 9/9/2009
Reuters
Ista Pharmaceuticals Inc's Bepreve treatment for itchy eyes from allergies was
approved by the US FDA.
...
BioLeap
to aid GlaxoSmithKline in drug development 4:31 PM 9/8/2009
Bizjournals.com
BioLeap specializes in computational fragment-based drug design.
GlaxoSmithKline will synthesize and test the compounds in biochemical and cellular assays.
...
Apotex
faces US ban on drug imports - analyst 12:17 PM 9/8/2009
Reuters
Apotex Inc faces a ban on products entering the US after the US FDA warned the Canadian
drugmaker about compliance issues at its Toronto factory.
...
Salix
says FDA approved stomach and heartburn drug 12:01 PM 9/8/2009
Forbes
Salix Pharmaceuticals said the US FDA approved its fast-dissolving drug
Metozolv (metoclopramide) which is intended to treat diabetic gastroparesis and heartburn.
...
Opexa
shares soar on multiple sclerosis drug data 10:10 AM 9/8/2009
Reuters
Opexa Therapeutics Inc said that more than 83 percent of patients taking
its experimental multiple sclerosis drug remained relapse-free after a year.
...
Vaxart
Awarded NIH Grant to Support Development of Orally
... 10:00 AM 9/8/2009
Reuters
Vaxart uses an
adjuvant that works through a toll-like receptor (TLR).
...
Osiris'
stem cell drug fails in two late-stage trials 8:59 AM 9/8/2009
Reuters
Osiris Therapeutics Inc said Prochymal did not show any statistical
benefit in either of the two late-stage trials that were evaluating the drug in Graft vs Host Disease (GvHD).
...
Protalix's
Gaucher drug gets FDA orphan drug status 7:57 AM 9/8/2009
Reuters
Protalix BioTherapeutics Inc was granted orphan drug status for its
experimental treatment prGCD for Gaucher disease.
...
XenoPort
ends study of back spasm drug candidate 6:52 AM 9/8/2009
Forbes
XenoPort Inc will stop developing its compound XP19986 as a potential back spasm
treatment because of "high variability" in the drug's effectiveness.
...
Will
China's Swine Flu Vaccine Work? 5:03 AM 9/8/2009
Forbes
Skeptics do not believe that a one-dose vaccine lacking an adjuvant to prime the body to
react to the dead virus and produce antigens will be as effective as a two-doses.
...
Sanofi
to make swine flu vaccine for Brazil 1:50 PM 9/7/2009
Forbes
French drugmaker Sanofi-Aventis signed a deal to make millions of swine flu vaccine
doses for Brazil which has the world's highest death toll from the virus.
...
Liver
cells may aid drug-safety studies 5:03 AM 9/7/2009
Boston Globe
Researchers collaborate to build a 3-D liver to show liver toxicity before
clinical trials.
...
FDA
staff note miscarriages in Glaxo vaccine data 12:17 PM 9/4/2009
Reuters
Proposed GlaxoSmithKline Cervarix vaccine findings cannot rule out a small
effect in pregnancies conceived in the three months immediately after vaccination.
...
<- Day Earlier | Today's News
|
